Spero Therapeutics
SPRO
SPRO
89 hedge funds and large institutions have $370M invested in Spero Therapeutics in 2020 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 34 increasing their positions, 23 reducing their positions, and 13 closing their positions.
Holders
89
Holders Change
+11
Holders Change %
+14.1%
% of All Funds
1.58%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
24
Increased
34
Reduced
23
Closed
13
Calls
$1.5M
Puts
$2.04M
Net Calls
-$539K
Net Calls Change
-$142K
Top Buyers
| 1 |
AVAX
1
Atlas Venture Associates XI
Cambridge,
Massachusetts
|
$26.7M |
| 2 |
BI
2
BVF Inc
San Francisco,
California
|
$43.5M |
| 3 |
3
BlackRock
New York
|
$33.6M |
| 4 |
4
Ameriprise
Minneapolis,
Minnesota
|
$5.15M |
| 5 |
5
Morgan Stanley
New York
|
$5.26M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
PCM
101
Prelude Capital Management
New York
| – | – | -300 | Closed |
|
|
HT
102
HAP Trading
New York
| – | – | – | – |
|
|
CFGS
103
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
104
Belvedere Trading
Chicago,
Illinois
| – | – | – | – |
|
|
EI
105
Ellevest Inc
New York
| $0 | 6 | +6 | New |
|